These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 6823797

  • 1. Use of nonsustained ventricular tachycardia as a guide to antiarrhythmic drug therapy in patients with malignant ventricular arrhythmia.
    Podrid PJ, Schoeneberger A, Lown B, Lampert S, Matos J, Porterfield J, Raeder E, Corrigan E.
    Am Heart J; 1983 Feb; 105(2):181-8. PubMed ID: 6823797
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiologic drug testing in patients with malignant ventricular arrhythmias: importance of stimulation at more than one ventricular site.
    Morady F, Hess D, Scheinman MM.
    Am J Cardiol; 1982 Nov; 50(5):1055-60. PubMed ID: 7137032
    [Abstract] [Full Text] [Related]

  • 3. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
    Volgman AS, Zheutlin TA, Mattioni TA, Parker MA, Kehoe RF.
    Am J Cardiol; 1992 Sep 15; 70(7):758-63. PubMed ID: 1519526
    [Abstract] [Full Text] [Related]

  • 4. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome.
    Bhandari AK, Hong R, Au P, McKay CR, Rahimtoola SH.
    Can J Cardiol; 1988 Mar 15; 4(2):80-4. PubMed ID: 3365601
    [Abstract] [Full Text] [Related]

  • 5. Decreased incidence of antiarrhythmic drug efficacy at electrophysiologic study associated with the use of a third extrastimulus.
    Swerdlow CD, Blum J, Winkle RA, Griffin JC, Ross DL, Mason JW.
    Am Heart J; 1982 Nov 15; 104(5 Pt 1):1004-11. PubMed ID: 7136990
    [Abstract] [Full Text] [Related]

  • 6. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G, Bach P, Haberl R.
    J Am Coll Cardiol; 1986 Oct 15; 8(4):949-58. PubMed ID: 3760368
    [Abstract] [Full Text] [Related]

  • 7. Programmed ventricular stimulation in predicting vulnerability to ventricular arrhythmias and their response to antiarrhythmic therapy.
    Mason JW, Swerdlow CD, Winkle RA, Griffin JC, Ross DL, Keefe DL, Clusin WT.
    Am Heart J; 1982 Apr 15; 103(4 Pt 2):633-9. PubMed ID: 7064805
    [Abstract] [Full Text] [Related]

  • 8. Reproducibility of ventricular tachycardia suppression by antiarrhythmic drug therapy during serial electrophysiologic testing in coronary artery disease.
    Garan H, Stavens CS, McGovern B, Kelly E, Ruskin JN.
    Am J Cardiol; 1986 Nov 01; 58(10):977-80. PubMed ID: 3776854
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups.
    Poole JE, Mathisen TL, Kudenchuk PJ, McAnulty JH, Swerdlow CD, Bardy GH, Greene HL.
    J Am Coll Cardiol; 1990 Sep 01; 16(3):657-65. PubMed ID: 2387939
    [Abstract] [Full Text] [Related]

  • 10. Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Philadelphia Arrhythmia Group.
    Kowey PR, Waxman HL, Greenspon A, Greenberg R, Poll D, Kutalek S, Gessman L, Muenz L.
    Am J Cardiol; 1990 Mar 01; 65(9):594-8. PubMed ID: 2309629
    [Abstract] [Full Text] [Related]

  • 11. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT, Nademanee K, Antimisiaris M, Pacifico A, Pruitt C, Godfrey R, Singh BN.
    Circulation; 1993 Sep 01; 88(3):1072-82. PubMed ID: 8353869
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG, Seiden SW, Matos JA, Waspe LE, Fisher JD.
    J Am Coll Cardiol; 1985 Sep 01; 6(3):539-44. PubMed ID: 2411776
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
    Kim SG, Felder SD, Waspe LE, Fisher JD.
    Am J Cardiol; 1986 Sep 01; 58(6):485-90. PubMed ID: 3529910
    [Abstract] [Full Text] [Related]

  • 19. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias.
    Schoenfeld MH, McGovern B, Garan H, Kelly E, Grant G, Ruskin JN.
    J Am Coll Cardiol; 1985 Aug 01; 6(2):298-306. PubMed ID: 4019918
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.